Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Biometric data

From: Long-term consumption of an obesogenic high fat diet prior to ischemia-reperfusion mediates cardioprotection via Epac1-dependent signaling

  Wt
ND
Wt
HFD
Epac1−/−
ND
Epac1−/−
HFD
Epac2−/−
ND
Epac2−/−
HFD
N 8 16 6 6 6 10
BW (g) 27.5 ± 1.6 44.5 ± 2.0& 24.2 ± 0.5 48.4 ± 1.1& 24.7 ± 0.6 38.8 ± 3.0&
HW (mg) 146.3 ± 8.2¤ 162.2 ± 6.7¤ 154.3 ± 8.6¤ 197.7 ± 6.0& 126.5 ± 7.2¤ 137.4 ± 5.3¤
HW/BW (mg/g) 5.3 ± 0.2 3.7 ± 0.2& 6.4 ± 0.4 4.1 ± 0.2& 5.2 ± 0.3 3.6 ± 0.2 &
LV volume (mm3) 108.6 ± 6.7 117.5 ± 5.2 96.8 ± 4.8 124.7 ± 8.8 96.0 ± 5.4 104.9 ± 2.7
Total fat (g) 1.7 ± 0.3 7.7 ± 0.5& 1.2 ± 0.1 8.6 ± 0.4& 1.1 ± 0.1 6.9 ± 0.7
 iWAT (g) 0.4 ± 0.1 2.0 ± 0.1& 0.3 ± 0.1 1.8 ± 0.1& 0.4 ± 0.1 1.9 ± 0.2&
 rWAT (g) 0.5 ± 0.1 2.1 ± 0.2& 0.3 ± 0.1 2.5 ± 0.2& 0.3 ± 0.1 2.0 ± 0.2&
 gWAT (g) 0.8 ± 0.2 3.6 ± 0.3& 0.6 ± 0.1 4.3 ± 0.2& 0.5 ± 0.1 3.0 ± 0.3
 rWAT + gWAT (g) 1.3 ± 0.2 5.7 ± 0.4& 0.9 ± 0.1 6.8 ± 0.3& 0.8 ± 0.1 5.1 ± 0.5
Visceral fat (% of BW) 4.6 ± 0.8 12.5 ± 0.5& 3.4 ± 0.5 14.1 ± 0.4& 3.4 ± 0.2 12.1 ± 0.7&
Body fat (% of BW) 6.1 ± 1.0 17.0 ± 0.5& 4.7 ± 0.4 17.8 ± 0.5& 4.6 ± 0.4 16.7 ± 1.0
  1. Values represent means ± s.e.m
  2. ND normal diet, HFD high fat diet, iWAT inguinal fat (subcutaneous fat), rWAT peri-renal fat, gWAT peri-gonadal fat, rWAT + gWAT visceral fat. & p < 0.05 vs. corresponding genotype on ND; p < 0.05 vs. Epac1−/− ND; ¤ p < 0.05 vs. Epac1−/− HFD
  3. Body and fat weights were measured at the end of the feeding protocol, while the heart weight was measured after the ex vivo perfusions. Left ventricular (LV) volume was determined during the infarct size assessment